CytoPherx's Series B Round

CytoPherx raised a round of funding on June 18, 2010.

CytoPherx, formerly Nephrion, is a clinical stage medical device company addressing inflammation based diseases and conditions with a selective cytopheresis-based inflammation modulating system.…

Articles about CytoPherx's Series B Round: